Cargando…

Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China

Background: With the adoption of powerful preventive and therapeutic measures, a large number of patients with COVID-19 have recovered and been discharged from hospitals in Wuhan, China. Prevention of epidemic rebound is a top priority of current works. However, information regarding post-discharge...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Nao, Wang, Wei, Gao, Yongzhe, Zhou, Junhui, Ye, Jiuhong, Xu, Zhipeng, Cao, Jing, Zhang, Junjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347902/
https://www.ncbi.nlm.nih.gov/pubmed/32719806
http://dx.doi.org/10.3389/fmed.2020.00373
_version_ 1783556681871917056
author Yan, Nao
Wang, Wei
Gao, Yongzhe
Zhou, Junhui
Ye, Jiuhong
Xu, Zhipeng
Cao, Jing
Zhang, Junjian
author_facet Yan, Nao
Wang, Wei
Gao, Yongzhe
Zhou, Junhui
Ye, Jiuhong
Xu, Zhipeng
Cao, Jing
Zhang, Junjian
author_sort Yan, Nao
collection PubMed
description Background: With the adoption of powerful preventive and therapeutic measures, a large number of patients with COVID-19 have recovered and been discharged from hospitals in Wuhan, China. Prevention of epidemic rebound is a top priority of current works. However, information regarding post-discharge quarantine and surveillance of recovered patients with COVID-19 is scarce. Methods: This study followed up 337 patients with COVID-19 in a Wuhan East-West Lake Fangcang shelter hospital during the post-discharge quarantine. Demographic, clinical characteristics, comorbidities, and chest computed tomography (CT) image, mental state, medication status, and nucleic acid test data were summarized and analyzed. Results: 21/337 (6.2%) patients were SARS-CoV-2 nucleic acid re-positive, and 4 /337(1.2%) patients were suspected positive. The median day interval between the discharge to nucleic acid re-positivity was 7.5 days (IQR, 6–13), ranging from 6 to 13 days. Cough/expectoration are the most common symptoms, followed by chest congestion/dyspnea during the 2 weeks post-discharge quarantine. Risk factors of nucleic acid re-positivity including the number of lobes infiltration (odds ratio[OR], 1.14; 95% CI, 1.09–1.19), distribution (OR, 0.16; 95% CI, 0.13–0.19), CT imaging feature of patchy shadowing accompanying with consolidation (OR, 9.36; 95% CI, 7.84–11.17), respiratory symptoms of cough accompanying with expectoration (OR, 1.39; 95% CI, 1.28–1.52), and chest congestion accompanying by dyspnea (OR, 1.42; 95% CI, 1.28–1.57). Conclusion: The 2 weeks post-discharge quarantine may be an effective measure to prevent the outbreak from rebounding from the recovered patients. The second week is a critical period during post-discharge quarantine. Special attention should be paid to cough, expectoration, chest congestion, and dyspnea in recovered COVID-19 patients. A few recovered patients may prolong the quarantine based on clinical symptoms and signs and nucleic acid results in the 2 weeks of medical observation.
format Online
Article
Text
id pubmed-7347902
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73479022020-07-26 Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China Yan, Nao Wang, Wei Gao, Yongzhe Zhou, Junhui Ye, Jiuhong Xu, Zhipeng Cao, Jing Zhang, Junjian Front Med (Lausanne) Medicine Background: With the adoption of powerful preventive and therapeutic measures, a large number of patients with COVID-19 have recovered and been discharged from hospitals in Wuhan, China. Prevention of epidemic rebound is a top priority of current works. However, information regarding post-discharge quarantine and surveillance of recovered patients with COVID-19 is scarce. Methods: This study followed up 337 patients with COVID-19 in a Wuhan East-West Lake Fangcang shelter hospital during the post-discharge quarantine. Demographic, clinical characteristics, comorbidities, and chest computed tomography (CT) image, mental state, medication status, and nucleic acid test data were summarized and analyzed. Results: 21/337 (6.2%) patients were SARS-CoV-2 nucleic acid re-positive, and 4 /337(1.2%) patients were suspected positive. The median day interval between the discharge to nucleic acid re-positivity was 7.5 days (IQR, 6–13), ranging from 6 to 13 days. Cough/expectoration are the most common symptoms, followed by chest congestion/dyspnea during the 2 weeks post-discharge quarantine. Risk factors of nucleic acid re-positivity including the number of lobes infiltration (odds ratio[OR], 1.14; 95% CI, 1.09–1.19), distribution (OR, 0.16; 95% CI, 0.13–0.19), CT imaging feature of patchy shadowing accompanying with consolidation (OR, 9.36; 95% CI, 7.84–11.17), respiratory symptoms of cough accompanying with expectoration (OR, 1.39; 95% CI, 1.28–1.52), and chest congestion accompanying by dyspnea (OR, 1.42; 95% CI, 1.28–1.57). Conclusion: The 2 weeks post-discharge quarantine may be an effective measure to prevent the outbreak from rebounding from the recovered patients. The second week is a critical period during post-discharge quarantine. Special attention should be paid to cough, expectoration, chest congestion, and dyspnea in recovered COVID-19 patients. A few recovered patients may prolong the quarantine based on clinical symptoms and signs and nucleic acid results in the 2 weeks of medical observation. Frontiers Media S.A. 2020-07-03 /pmc/articles/PMC7347902/ /pubmed/32719806 http://dx.doi.org/10.3389/fmed.2020.00373 Text en Copyright © 2020 Yan, Wang, Gao, Zhou, Ye, Xu, Cao and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yan, Nao
Wang, Wei
Gao, Yongzhe
Zhou, Junhui
Ye, Jiuhong
Xu, Zhipeng
Cao, Jing
Zhang, Junjian
Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China
title Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China
title_full Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China
title_fullStr Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China
title_full_unstemmed Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China
title_short Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China
title_sort medium term follow-up of 337 patients with coronavirus disease 2019 (covid-19) in a fangcang shelter hospital in wuhan, china
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347902/
https://www.ncbi.nlm.nih.gov/pubmed/32719806
http://dx.doi.org/10.3389/fmed.2020.00373
work_keys_str_mv AT yannao mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT wangwei mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT gaoyongzhe mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT zhoujunhui mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT yejiuhong mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT xuzhipeng mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT caojing mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina
AT zhangjunjian mediumtermfollowupof337patientswithcoronavirusdisease2019covid19inafangcangshelterhospitalinwuhanchina